NervGen Pharma Corp.
NGENF News Today: Stay Updated with the Latest NervGen Pharma Corp. News in Real Time
Find NGENF news now at Meyka AI. Stay informed with the latest NervGen Pharma Corp. stocks updates, including price news, market analysis, and expert insights.

UBQU Stock Crashes 99% on Pink Sheets Exchange May 2026
UBQU stock plummets 99% to $0.000001 on PNK exchange. Ubiquitech Software faces severe distress with negative metrics and C+ rating.

KEC.TO Stock Bounces Back: Kiwetinohk Energy Up 0.12% on May 4
KEC.TO stock rises 0.12% to C$24.73 on May 4, 2026. Energy transition company shows resilience with strong fundamentals and B+ rating.

VRTS.TO Stock Doubles on May 4, 2026: Vertiqal Studios Surges 100%
VRTS.TO stock price doubled to C$0.01 on May 4, 2026, marking a 100% intraday gain on the TSX. Vertiqal Studios Corp. shows strong momentum.

NSRX Insider Trade: Rubin Eyal CFO Stock Options Filing May 04, 2026
Nasus Pharma CFO Rubin Eyal files initial ownership of 40,549 share options valued at $306,550. Form 3 filing reveals executive equity stake in NSRX.

eBay Shares Jump Premarket After GameStop Proposes $56 Billion Buyout
Shares of eBay Inc. surged sharply in premarket trading after reports emerged that GameStop Corp. is preparing a massive $56 billion buyout offer. The news created strong excitement in the stock market, as investors reacted to the possibility of one of the largest deals in the e-commerce and gaming sectors. The proposed acquisition has sparkedβ¦

ATLN Stock: CFO Murphy Kevin James Insider Trading Activity May 04, 2026
ATLN CFO Murphy Kevin James files insider trading disclosure for 400,000 incentive stock options valued at $1.38M.

TAUR.CN Stock Surges 150% on May 4, 2026 β Taurus Gold Corp
TAUR.CN stock jumps 150% to C$0.075 on May 4, 2026. Taurus Gold Corp explores precious metals in Yukon Territory.

AMMP.CN Stock Bounces at C$0.03 on CNQ Exchange May 2026
AMMP.CN stock trades at C$0.03 on CNQ. AmmPower Corp explores lithium and develops green ammonia technology in Canada.

Sudarshan Pharma Stock Rises 4% After Reporting Strong Q4 Profits and Revenue Growth
Sudarshan Pharma Stock gained around 4% in early trade after the company reported a strong set of Q4 FY26 results. The market reacted positively as both profit and revenue showed solid double-digit growth. From the latest financial updates, we can see that investors responded quickly to the earnings surprise. The pharma sector also remained active,β¦